Dr. Yevgeniy Gindin is Director of Computational Biology & Bioinformatics at Revolution Medicines, where he leads a multidisciplinary team that powers precision-oncology programs with AI/ML and cloud-scale multi-omic analytics. Drawing on nearly a decade in pharma, he has turned terabytes of genomic and real-world data into insights that advanced RAS-targeted therapies into the clinic. Dr. Gindin earned his PhD in Bioinformatics through the National Cancer Institute–Boston University partnership.